marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-08-2023
ACADIA Pharmaceuticals Income Statement 2011-2024 | ACAD
Annual Income Statement ACADIA Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.53 B | 7.56 B | 5.89 B | 2.9 B | 3.76 B | 3.78 B | 2.08 B | 2.96 B | 2.04 B | 339 M | 79.8 M |
Shares |
160 M | 157 M | 147 M | 127 M | 123 M | 116 M | 101 M | 97.2 M | 85.7 M | 55.1 M | 52.2 M |
Historical Prices |
22.5 | 48 | 39.9 | 22.8 | 29.9 | 34.6 | 20.7 | 30.4 | 23.3 | 6.03 | 1.51 |
Net Income |
-168 M | -282 M | -235 M | -245 M | -289 M | -271 M | -164 M | -92.5 M | -37.9 M | -20.8 M | -22.8 M |
Revenue |
484 M | 442 M | 339 M | 224 M | 125 M | 17.3 M | 61 K | 120 K | 1.14 M | 4.91 M | 2.07 M |
Cost of Revenue |
10.8 M | 10.2 M | 11.3 M | 12.4 M | 9.08 M | - | - | - | - | - | - |
Gross Profit |
473 M | 421 M | 319 M | 205 M | 112 M | 12.9 M | - | - | - | - | 2.07 M |
Operating Income |
-170 M | -287 M | -247 M | -247 M | -292 M | -273 M | -165 M | -93.2 M | -38.3 M | -20.9 M | -22.9 M |
Interest Expense |
-2.33 M | -997 K | 997 K | -1.84 M | - | - | - | - | - | - | - |
EBITDA |
-168 M | -284 M | -244 M | -244 M | -290 M | -271 M | -164 M | -93 M | -38.2 M | -20.8 M | -22.6 M |
Operating Expenses |
- | 708 M | 566 M | 453 M | 404 M | 286 M | 165 M | 93.4 M | 39.4 M | 25.8 M | 24.9 M |
General and Administrative Expenses |
396 M | 389 M | 326 M | 266 M | 255 M | 186 M | 90.8 M | 32.7 M | 12.7 M | 7 M | 7.61 M |
All numbers in USD currency
Quarterly Income Statement ACADIA Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
162 M | 162 M | - | 162 K | 161 M | 161 M | 161 M | 160 K | 160 M | 160 M | 158 M | 157 M | 155 M | 155 M | 146 M | 144 M | 144 M | 144 M | 125 M | 125 M | 125 M | 124 M | 122 M | 122 M | 122 M | 121 M | 117 M | 113 M | 111 M | 102 M | 101 M | 100 M | 100 M | 100 M | 99.5 M | 99 M | 93 M | 91.1 M | 89.5 M | 83.4 M | 78.7 M | 73.3 M | 53.9 M | 53 M | 52.9 M | 52.9 M | 52.8 M | 52.7 M | 52.9 M |
Net Income |
-43 M | - | - | -34 M | -113 M | -43.1 M | -14.5 M | -43.9 M | -66.4 M | -66.8 M | -84.7 M | -42.1 M | -88 M | -53 M | -42 M | -54.9 M | -85.3 M | -65.5 M | -62.1 M | -63.3 M | -54.3 M | -68.9 M | -65.2 M | -67.4 M | -87.8 M | -78.7 M | -71.6 M | -71.3 M | -49.8 M | -45.8 M | -38.9 M | -39.4 M | -40.4 M | -28.4 M | -24.8 M | -21.5 M | -17.8 M | -12 M | -10.7 M | -9.08 M | -6.12 M | -6.81 M | -2.4 M | -5.42 M | -6.22 M | -5.3 M | -5.08 M | -6.56 M | -5.83 M |
Revenue |
118 M | - | - | 135 M | 115 M | 131 M | 132 M | 115 M | 107 M | 121 M | 121 M | 110 M | 90.1 M | 98.3 M | 94.6 M | 83.2 M | 63 M | 59.6 M | 58.3 M | 57.1 M | 48.9 M | 43.6 M | 35.6 M | 30.5 M | 15.3 M | 12 M | 5.27 M | 97 K | 4 K | 17 K | 39 K | 1 K | 4 K | 47 K | 15 K | 28 K | 30 K | 37 K | 240 K | 451 K | 417 K | 380 K | 3.48 M | 599 K | 450 K | 588 K | 584 K | 460 K | 435 K |
Cost of Revenue |
1.67 M | - | - | 2.67 M | 2.95 M | - | 3.69 M | 2.53 M | 2.18 M | - | 2 M | 2.9 M | 2.8 M | - | 2.42 M | 2.96 M | 2.95 M | - | 3.84 M | 3.56 M | 2.15 M | - | 2.14 M | 2.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 128 M | 128 M | 113 M | 104 M | 118 M | 119 M | 107 M | 87.3 M | 95.3 M | 92.2 M | 80.2 M | 60 M | 56.7 M | 54.5 M | 53.5 M | 46.7 M | 41.1 M | 33.4 M | 28.3 M | 13 M | 10.3 M | 4.42 M | -429 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-53.6 M | - | - | -33.7 M | -113 M | - | -15.3 M | -43.7 M | -66.8 M | - | -85.9 M | -44 M | -89.5 M | - | -45.4 M | -57.1 M | -87.6 M | - | -61.3 M | -64.1 M | -54.8 M | - | -65.6 M | -68 M | -88.7 M | - | -72.4 M | -71.9 M | -50.3 M | - | -39 M | -39.5 M | -40.6 M | - | -25 M | -21.7 M | -18 M | - | -10.8 M | -9.16 M | -6.16 M | - | -2.41 M | -5.43 M | -6.23 M | - | -5.09 M | -6.58 M | -5.86 M |
Interest Expense |
4.84 M | - | - | -497 K | 340 K | - | 383 K | 178 K | -145 K | - | -202 K | 437 K | -1.5 M | - | 747 K | -12 K | - | - | -1.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-53.2 M | - | - | -32.6 M | -112 M | - | -14.9 M | -42.6 M | -66.2 M | - | -84.9 M | -43.4 M | -89.2 M | - | -44.4 M | -56.4 M | -87.2 M | - | -60.2 M | -63.3 M | -54.4 M | - | -64.7 M | -67.5 M | -88.5 M | - | -71.8 M | -71.6 M | -50.1 M | - | -38.5 M | -39.1 M | -40.4 M | - | -24.8 M | -21.6 M | -17.9 M | - | -10.8 M | -9.13 M | -6.15 M | - | -2.32 M | -5.43 M | -6.2 M | - | -4.84 M | -6.36 M | -5.67 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.3 M | - | 39 M | 39.5 M | 40.6 M | - | 25 M | 21.8 M | 18 M | - | 11.1 M | 9.61 M | 6.58 M | - | 5.88 M | 6.03 M | 6.68 M | - | 5.68 M | 7.04 M | 6.3 M |
General and Administrative Expenses |
101 M | - | - | 89.9 M | 96.7 M | - | 81.7 M | 96.8 M | 112 M | - | 81.6 M | 84.3 M | 102 M | - | 72.7 M | 68 M | 93.1 M | - | 61.1 M | 69.5 M | 60.9 M | - | 61.6 M | 61.1 M | 65.7 M | - | 50.5 M | 50.8 M | 27.5 M | - | 20.3 M | 21.1 M | 24.3 M | - | 8.06 M | 7.95 M | 6.32 M | - | 3.8 M | 2.5 M | 2.15 M | - | 1.48 M | 1.56 M | 1.66 M | - | 1.52 M | 2.73 M | 1.88 M |
All numbers in USD currency